These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 17048796)

  • 1. [Protection of Croatian Army draftees and professional soldiers from hepatitis A].
    Puntarić D; Grgic M; Bacun-Ivcek L
    Acta Med Croatica; 2006 Sep; 60(4):389-92. PubMed ID: 17048796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis A vaccines.
    Nothdurft HD
    Expert Rev Vaccines; 2008 Jul; 7(5):535-45. PubMed ID: 18564009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Viral hepatitis of enteric origin].
    Debord T; Buisson Y
    Bull Soc Pathol Exot; 1998; 91(5 Pt 1-2):428-31. PubMed ID: 10078380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis a in Korea: epidemiological shift and call for vaccine strategy.
    Lee D; Cho YA; Park Y; Hwang JH; Kim JW; Kim NY; Lee DH; Lee W; Jeong SH
    Intervirology; 2008; 51(2):70-4. PubMed ID: 18434743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis A vaccines and the elderly.
    Genton B; D'Acremont V; Furrer HJ; Hatz C; Louis Loutan
    Travel Med Infect Dis; 2006 Dec; 4(6):303-12. PubMed ID: 17098625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of universal hepatitis A immunization of children in Minsk City, Belarus: four-year follow-up.
    Fisenka EG; Germanovich FA; Glinskaya IN; Lyabis OI; Rasuli AM
    J Viral Hepat; 2008 Oct; 15 Suppl 2():57-61. PubMed ID: 18837836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in hepatitis A seroprevalence among geographical regions in Turkey: a need for regional vaccination recommendations.
    Ceyhan M; Yildirim I; Kurt N; Uysal G; Dikici B; Ecevit C; Aydogan A; Koc A; Yasa O; Köseoğlu M; Onal K; Hacimustafaoglu M; Celebi S
    J Viral Hepat; 2008 Oct; 15 Suppl 2():69-72. PubMed ID: 18837839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of the long-term protection after hepatitis A and B vaccination.
    Van Damme P; Van Herck K
    Travel Med Infect Dis; 2007 Mar; 5(2):79-84. PubMed ID: 17298912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunogenicity of vaccines against viral hepatitis A and B in the population above 40 years of age -- impact of risk factors].
    Chlíbek R; Smetana J; Sindelár R; Cecetková B; Prymula R; Kohl I
    Epidemiol Mikrobiol Imunol; 2007 Aug; 56(3):119-28. PubMed ID: 17900060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.
    Wörns MA; Teufel A; Kanzler S; Shrestha A; Victor A; Otto G; Lohse AW; Galle PR; Höhler T
    Am J Gastroenterol; 2008 Jan; 103(1):138-46. PubMed ID: 17970833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiologic characteristics and military implications of hemorrhagic fever with renal syndrome in croatia.
    Mulić R; Ropac D
    Croat Med J; 2002 Oct; 43(5):581-6. PubMed ID: 12402401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevalence of anti-HAV antibodies in Warsaw population].
    Janaszek-Seydlitz W; Bucholc B; Wiatrzyk A
    Przegl Epidemiol; 2007; 61(4):675-82. PubMed ID: 18572499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and factors associated with self-reported vaccination rates among US adults at high risk of vaccine-preventable hepatitis.
    Chen H; Cantrell CR
    Curr Med Res Opin; 2006 Dec; 22(12):2489-96. PubMed ID: 17257463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Risks for measles and mumps in recruits of the Croatian army].
    Perić D; Gotovac P
    Lijec Vjesn; 2002 Oct; 124(10):301-4. PubMed ID: 12619438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of hepatitis A before and after the introduction of a universal vaccination programme in Catalonia, Spain.
    Domínguez A; Oviedo M; Carmona G; Jansá JM; Borrás E; Salleras L; Plasència A
    J Viral Hepat; 2008 Oct; 15 Suppl 2():51-6. PubMed ID: 18837835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis A vaccination coverage among children aged 24-35 months--United States, 2004-2005.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Jul; 56(27):678-81. PubMed ID: 17625495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The underestimated risk of hepatitis A and hepatitis B: benefits of an accelerated vaccination schedule.
    Keystone JS; Hershey JH
    Int J Infect Dis; 2008 Jan; 12(1):3-11. PubMed ID: 17643334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral hepatitis A, active component, U.S. Armed Forces, 2000-2010.
    Armed Forces Health Surveillance Center (AFHSC)
    MSMR; 2011 Aug; 18(8):2-4. PubMed ID: 21879784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging risk for viral hepatitis A in Croatian adults.
    Mićović V; Cattunar A; Stimac D; Capak K; Stojanovic D; Jurisic D
    Med Glas (Zenica); 2010 Aug; 7(2):169-72. PubMed ID: 21258315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of immunity after hepatitis A vaccination in HIV-infected persons.
    Overton ET; Nurutdinova D; Sungkanuparph S; Seyfried W; Groger RK; Powderly WG
    J Viral Hepat; 2007 Mar; 14(3):189-93. PubMed ID: 17305885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.